Travere Therapeutics Inc (TVTX)
5.245
-0.14
(-2.69%)
USD |
NASDAQ |
Apr 26, 16:00
5.245
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Gross Profit (Quarterly): 40.50M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 40.50M |
September 30, 2023 | 35.81M |
June 30, 2023 | 57.71M |
March 31, 2023 | 51.87M |
December 31, 2022 | 28.47M |
September 30, 2022 | 26.96M |
June 30, 2022 | 52.12M |
March 31, 2022 | 46.35M |
December 31, 2021 | -37.34M |
September 30, 2021 | 66.62M |
June 30, 2021 | 52.97M |
March 31, 2021 | 45.76M |
December 31, 2020 | 48.91M |
September 30, 2020 | 49.95M |
June 30, 2020 | 46.94M |
March 31, 2020 | 46.40M |
December 31, 2019 | 44.96M |
September 30, 2019 | 42.86M |
June 30, 2019 | 43.73M |
March 31, 2019 | 38.55M |
December 31, 2018 | 42.17M |
September 30, 2018 | 39.57M |
Date | Value |
---|---|
June 30, 2018 | 40.16M |
March 31, 2018 | 36.82M |
December 31, 2017 | 41.00M |
September 30, 2017 | 39.42M |
June 30, 2017 | 38.00M |
March 31, 2017 | 32.91M |
December 31, 2016 | 36.12M |
September 30, 2016 | 32.37M |
June 30, 2016 | 32.29M |
March 31, 2016 | 28.25M |
December 31, 2015 | 29.69M |
September 30, 2015 | 27.49M |
June 30, 2015 | 23.43M |
March 31, 2015 | 17.10M |
December 31, 2014 | 13.75M |
September 30, 2014 | 8.151M |
June 30, 2014 | 5.707M |
March 31, 2014 | 0.027M |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-37.34M
Minimum
Dec 2021
66.62M
Maximum
Sep 2021
41.66M
Average
46.35M
Median
Mar 2022
Gross Profit (Quarterly) Benchmarks
AtriCure Inc | 79.82M |
Bio-Rad Laboratories Inc | 366.36M |
Artivion Inc | 61.10M |
Shockwave Medical Inc | 177.66M |
Perspective Therapeutics Inc | -- |